Artal Group S.A.
- SEC CIK
- 0001053906
- Latest filing
- Aug 13, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 11, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 132
- −3 vs. Q1 2022
- Portfolio value
- $1.80B
- −$566.9M (−24.0%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 400,000 | $151.6M | 8.4% | −187,500−31.9% | Reduced | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 71,178,364 | $132.4M | 7.4% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 650,000 | $105.2M | 5.8% | −15,000−2.3% | Reduced | History |
| WWWW International, Inc. | COM | 14,818,300 | $94.7M | 5.3% | 00.0% | Unchanged | History |
| SGENSeagen Inc. | COM | 525,000 | $92.9M | 5.2% | −125,000−19.2% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 600,000 | $87.5M | 4.9% | −50,000−7.7% | Reduced | History |
| MRTXMirati Therapeutics, Inc. | COM | 1,100,000 | $73.8M | 4.1% | −250,000−18.5% | Reduced | History |
| Bellus Health Inc New07987C204 | COM NEW | 7,000,000 | $64.7M | 3.6% | −1,500,000−17.6% | Reduced | – |
| FATEFate Therapeutics Inc | COM | 2,600,000 | $64.4M | 3.6% | +600,000+30.0% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 1,275,000 | $50.1M | 2.8% | +275,000+27.5% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 8,750,034 | $48.0M | 2.7% | +6,300,034+257.1% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 4,000,000 | $43.0M | 2.4% | 00.0% | Unchanged | History |
| SEERSeer, Inc. | COM CL A | 4,750,000 | $42.5M | 2.4% | 00.0% | Unchanged | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 1,500,000 | $39.7M | 2.2% | 00.0% | Unchanged | History |
| IGMSIGM Biosciences, Inc. | COM | 2,000,000 | $36.1M | 2.0% | 00.0% | Unchanged | History |
| MORFMorphic Holding, Inc. | COM | 1,650,000 | $35.8M | 2.0% | 00.0% | Unchanged | History |
| KRYSKrystal Biotech, Inc. | COM | 500,000 | $32.8M | 1.8% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $23.4M | 1.3% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 900,000 | $22.2M | 1.2% | +50,000+5.9% | Added | History |
| GOSSGossamer Bio, Inc. | COM | 2,358,968 | $19.7M | 1.1% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 1,000,000 | $19.7M | 1.1% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 1,050,000 | $19.2M | 1.1% | 00.0% | Unchanged | History |
| EQRXEQRx, Inc. | COM | 4,000,000 | $18.8M | 1.0% | 00.0% | Unchanged | History |
| SDGRSchrodinger, Inc. | COM | 700,000 | $18.5M | 1.0% | 00.0% | Unchanged | History |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $18.5M | 1.0% | 00.0% | Unchanged | History |
| ERASErasca, Inc. | COM | 3,172,221 | $17.7M | 1.0% | 00.0% | Unchanged | History |
| DNLIDenali Therapeutics Inc. | COM | 600,000 | $17.7M | 1.0% | 00.0% | Unchanged | History |
| REPLReplimune Group, Inc. | COM | 900,000 | $15.7M | 0.9% | 00.0% | Unchanged | History |
| SAGESage Therapeutics, Inc. | COM | 450,000 | $14.5M | 0.8% | −300,000−40.0% | Reduced | History |
| NTLAIntellia Therapeutics, Inc. | COM | 275,000 | $14.2M | 0.8% | 00.0% | Unchanged | History |
| EVOEvotec SE | SPONSORED ADS | 1,149,425 | $13.8M | 0.8% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 700,000 | $11.7M | 0.7% | 00.0% | Unchanged | History |
| MRSNMersana Therapeutics, Inc. | COM | 2,200,000 | $10.2M | 0.6% | 00.0% | Unchanged | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $10.1M | 0.6% | 00.0% | Unchanged | History |
| RPTXRepare Therapeutics Inc. | COM | 700,000 | $9.79M | 0.5% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 3,000,000 | $9.75M | 0.5% | +2,000,000+200.0% | Added | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 850,000 | $9.61M | 0.5% | 00.0% | Unchanged | History |
| TRMLTourmaline Bio, Inc. | COM | 2,064,262 | $9.31M | 0.5% | 00.0% | Unchanged | History |
| KLRSKalaris Therapeutics, Inc. | COM | 2,323,371 | $9.06M | 0.5% | 00.0% | Unchanged | History |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 2,273,530 | $8.64M | 0.5% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 400,000 | $8.24M | 0.5% | 00.0% | Unchanged | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,000,000 | $7.79M | 0.4% | 00.0% | Unchanged | History |
| Omega Alpha SpacG6749V107 | CL A | 750,000 | $7.39M | 0.4% | 00.0% | Unchanged | – |
| IMAImageneBio, Inc. | COM | 1,549,513 | $6.86M | 0.4% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 4,883,200 | $6.40M | 0.4% | +883,200+22.1% | Added | History |
| VERVVerve Therapeutics, Inc. | COM | 400,000 | $6.11M | 0.3% | 00.0% | Unchanged | History |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $6.05M | 0.3% | 00.0% | Unchanged | History |
| Exscientia PLC30223G102 | ADS | 550,000 | $5.99M | 0.3% | 00.0% | Unchanged | – |
| AGENAgenus Inc | COM NEW | 3,000,000 | $5.82M | 0.3% | −2,500,000−45.5% | Reduced | History |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 2,152,291 | $5.70M | 0.3% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $5.68M | 0.3% | 00.0% | Unchanged | – |
| KRONKronos Bio, Inc. | COM | 1,542,954 | $5.62M | 0.3% | 00.0% | Unchanged | History |
| DSGNDesign Therapeutics, Inc. | COM | 400,000 | $5.60M | 0.3% | 00.0% | Unchanged | History |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $5.38M | 0.3% | 00.0% | Unchanged | History |
| OTLYOatly Group AB | SPONSORED ADS | 1,500,000 | $5.19M | 0.3% | 00.0% | Unchanged | History |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $5.11M | 0.3% | 00.0% | Unchanged | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 593,030 | $5.05M | 0.3% | 00.0% | Unchanged | History |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 1,000,000 | $4.84M | 0.3% | 00.0% | Unchanged | History |
| CFRXCONTRAFECT Corp | COM NEW | 1,500,000 | $4.61M | 0.3% | 00.0% | Unchanged | History |
| CYPHCypherpunk Technologies Inc. | COM | 4,000,000 | $4.60M | 0.3% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM | 700,000 | $4.56M | 0.3% | 00.0% | Unchanged | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $4.05M | 0.2% | 00.0% | Unchanged | History |
| ALXOAlx Oncology Holdings Inc | COM | 500,000 | $4.04M | 0.2% | 00.0% | Unchanged | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,040,882 | $3.87M | 0.2% | 00.0% | Unchanged | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 4,000,000 | $3.85M | 0.2% | +500,000+14.3% | Added | History |
| SESea Ltd | SPONSORD ADS | 57,500 | $3.84M | 0.2% | 00.0% | Unchanged | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $3.80M | 0.2% | 00.0% | Unchanged | History |
| PFTAPerception Capital Corp. III | CLASS A ORD SHS | 380,000 | $3.71M | 0.2% | 00.0% | Unchanged | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 450,000 | $3.66M | 0.2% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 250,000 | $3.63M | 0.2% | 00.0% | Unchanged | – |
| ACIUAC Immune SA | SHS | 1,000,000 | $3.61M | 0.2% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 525,000 | $3.61M | 0.2% | 00.0% | Unchanged | History |
| ADVMAdverum Biotechnologies, Inc. | COM | 3,000,000 | $3.60M | 0.2% | 00.0% | Unchanged | History |
| APTXAptinyx Inc. | COM | 6,116,493 | $3.41M | 0.2% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $3.30M | 0.2% | 00.0% | Unchanged | History |
| IVVDInvivyd, Inc. | COM | 1,000,000 | $3.28M | 0.2% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 250,000 | $3.21M | 0.2% | 00.0% | Unchanged | History |
| RUBYRubius Therapeutics, Inc. | COM | 3,701,580 | $3.15M | 0.2% | 00.0% | Unchanged | History |
| HOOKHOOKIPA Pharma Inc. | COM | 1,849,616 | $3.02M | 0.2% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,200,000 | $2.94M | 0.2% | 00.0% | Unchanged | History |
| VIGLVigil Neuroscience, Inc. | COM | 1,121,191 | $2.89M | 0.2% | 00.0% | Unchanged | History |
| MIRMirion Technologies, Inc. | COM CL A | 500,000 | $2.88M | 0.2% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 550,000 | $2.73M | 0.2% | 00.0% | Unchanged | History |
| CINCCinCor Pharma, Inc. | COM | 137,010 | $2.58M | 0.1% | +137,010 | New | History |
| SANASana Biotechnology, Inc. | COM | 400,000 | $2.57M | 0.1% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 700,000 | $2.43M | 0.1% | 00.0% | Unchanged | History |
| ZYMEZymeworks Inc. | COM | 450,000 | $2.38M | 0.1% | 00.0% | Unchanged | History |
| BBIOBridgeBio Pharma, Inc. | COM | 250,000 | $2.27M | 0.1% | 00.0% | Unchanged | History |
| TCRRTCR2 Therapeutics Inc. | COM | 750,000 | $2.17M | 0.1% | 00.0% | Unchanged | History |
| TILInstil Bio, Inc. | COM | 450,000 | $2.08M | 0.1% | 00.0% | Unchanged | History |
| SNTISenti Biosciences Holdings, Inc. | COM | 1,055,555 | $2.07M | 0.1% | +1,055,555 | New | History |
| ADAGAdagene Inc. | ADS | 1,000,000 | $2.07M | 0.1% | 00.0% | Unchanged | History |
| IMMPIMMUTEP Ltd | SPONSORED ADS | 1,000,000 | $2.03M | 0.1% | 00.0% | Unchanged | History |
| YI111, Inc. | ADS | 966,349 | $1.99M | 0.1% | 00.0% | Unchanged | History |
| NEXINexImmune, Inc. | COM | 1,200,000 | $1.93M | 0.1% | 00.0% | Unchanged | History |
| LENZLENZ Therapeutics, Inc. | COM | 700,000 | $1.93M | 0.1% | 00.0% | Unchanged | History |
| HARPHarpoon Therapeutics, Inc. | COM | 1,000,000 | $1.91M | 0.1% | 00.0% | Unchanged | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 750,000 | $1.87M | 0.1% | 00.0% | Unchanged | History |
| SLDBSolid Biosciences Inc. | COM | 3,000,000 | $1.85M | 0.1% | 00.0% | Unchanged | History |
| GRTSGritstone bio, Inc. | COM | 750,000 | $1.81M | 0.1% | 00.0% | Unchanged | History |
Options (3)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q1 2022 (8)
Positions held at the end of Q1 2022 that are gone from this filing.
| Security | Class | Shares in Q1 2022 | Value in Q1 2022 | % of portfolio in Q1 2022 | History |
|---|---|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | COM | 800,100 | $18.9M | 0.8% | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 200,000 | $10.2M | 0.4% | History |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,000,000 | $9.30M | 0.4% | History |
| TGTXTG Therapeutics, Inc. | COM | 800,000 | $7.61M | 0.3% | History |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $5.98M | 0.3% | History |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 500,000 | $4.93M | 0.2% | – |
| XPXP Inc. | CL A | 35,000 | $1.05M | <0.1% | History |
| DNAGinkgo Bioworks Holdings, Inc. | CL A SHS | 50,000 | $202.0K | <0.1% | History |